SMS Lifesciences India Ltd - 540679 - KYC Update (Communication To Shareholders)
Request to shareholders to update their KYC details.27-02-2024
SMS Lifesciences India Ltd - 540679 - KYC Update (Communication To Shareholders)
Request to shareholders to update their KYC details.SMS Lifesciences India Ltd - 540679 - Newspaper Publication (Financial Results)
Enclosed are the copies of Newspaper advertisement.SMS Lifesciences India Ltd - 540679 - Promoter Reclassification (Not Approved)
The reclassification request was not approved by the Board.SMS Lifesciences India Ltd - 540679 - Board Meeting Outcome for Financial Results For Quarter And Nine-Months Ended December 31, 2023
Outcome of Board Meeting.SMS Lifesciences India Ltd - 540679 - Board Meeting Intimation for 88Th Board Meeting (10.02.2024)
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve 1. Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023. 2. Request of reclassification received from Mr. Ramesh Babu, promoter of the Company. 3. Any other item as may be decided by the Board of Directors.SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TV PraveenSMS Lifesciences India Ltd - 540679 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance CertificateSMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TV PraveenSMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudeepthi GopineediSMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TV Praveen